Parallax Volatility Advisers, L.P. Arrowhead Pharmaceuticals, Inc. Transaction History

Parallax Volatility Advisers, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$43.82 - $85.37 $182,159 - $354,883	-4,157 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$33.21 - $51.27 $138,053 - $213,129	4,157 New	4,157 $179,000
Q4 2019 Feb 14, 2020	SELL	$28.14 - $73.01 $236,263 - $612,991	-8,396 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$26.26 - $34.86 $216,198 - $287,002	8,233 Added 5050.92%	8,396 $236,000
Q1 2019 May 15, 2019	SELL	$12.05 - $20.18 $146,985 - $246,155	-12,198 Reduced 98.68%	163 $3,000

Q4 2018 Feb 14, 2019	BUY	$10.74 - $19.7 $122,285 - $224,304	11,386 Added 1167.79%	12,361 $154,000
Q2 2018 Aug 14, 2018	BUY	$6.37 - $14.02 $6,210 - $13,669	975 New	975 $13,000

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.